Literature DB >> 1850428

Phosphorylation of DNA topoisomerase II in a human tumor cell line.

D J Kroll1, T C Rowe.   

Abstract

The phosphorylation of the nuclear enzyme DNA topoisomerase II was characterized from HeLa human cervical carcinoma cells labeled with 32Pi. Analysis of topoisomerase II immunoprecipitates from 32P-labeled HeLa cells indicated that phosphorylation of the enzyme occurred at serine residues. Incorporation of 32P into topoisomerase II was not due to other types of phosphomodifications such as poly(ADP-ribosylation) or covalent interactions of the enzyme with nucleic acids. The stability of topoisomerase II protein and topoisomerase II phosphorylation was also investigated in HeLa cells. Topoisomerase II protein was relatively stable, having a half-life of approximately 27 h. Phosphorylation of HeLa topoisomerase II was also remarkably stable with a T1/2 of 17 h.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850428

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2.

Authors:  S Taagepera; P N Rao; F H Drake; G J Gorbsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 2.  Altered DNA topoisomerase II in multidrug resistance.

Authors:  W T Beck; M K Danks; J S Wolverton; B Granzen; M Chen; C A Schmidt; B Y Bugg; E Friche; D P Suttle
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.

Authors:  D A Burden; L J Goldsmith; D M Sullivan
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

Review 4.  Multilevel therapeutic targeting by topoisomerase inhibitors.

Authors:  P J Smith; S Souès
Journal:  Br J Cancer Suppl       Date:  1994-09

Review 5.  Role of protein kinases in antitumor drug resistance.

Authors:  H Grunicke; J Hofmann; I Utz; F Uberall
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

6.  Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.

Authors:  M K Ritke; D Roberts; W P Allan; J Raymond; V V Bergoltz; J C Yalowich
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

7.  Functional dissection of the phosphorylated termini of fission yeast DNA topoisomerase II.

Authors:  K Shiozaki; M Yanagida
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

8.  Mechanisms regulating resistance to inhibitors of topoisomerase II.

Authors:  Ram N Ganapathi; Mahrukh K Ganapathi
Journal:  Front Pharmacol       Date:  2013-08-01       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.